×
COMPASS Pathways Common Stock Net 2019-2024 | CMPS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
COMPASS Pathways common stock net from 2019 to 2024. Common stock net can be defined as the value of common equity ownership.
View More
COMPASS Pathways Common Stock Net 2019-2024 | CMPS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
COMPASS Pathways common stock net from 2019 to 2024. Common stock net can be defined as the value of common equity ownership.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$92.8B
Cencora (COR)
$49.5B
DiDi Global (DIDIY)
$22.6B
Natera (NTRA)
$22.2B
ICON (ICLR)
$16.3B
Revvity (RVTY)
$15B
Avantor (AVTR)
$14.6B
BioMerieux (BMXMF)
$14.2B
Viatris (VTRS)
$13.5B
CochLear (CHEOY)
$12.9B
Solventum (SOLV)
$12.9B
Doximity (DOCS)
$10.8B
Medpace Holdings (MEDP)
$10.7B
EUROFINS SCIENT (ERFSF)
$10.1B
HealthEquity (HQY)
$9.4B
Sonic Healthcare (SKHHY)
$8.7B
Charles River Laboratories (CRL)
$8.3B
Bausch + Lomb (BLCO)
$6.3B
Amplifon S.p.A (AMFPF)
$6.1B
BrightSpring Health Services (BTSG)
$4.1B
Organon (OGN)
$4.1B
Sotera Health (SHC)
$3.9B
Surgery Partners (SGRY)
$3.3B
Concentras Parent (CON)
$3B
Alignment Healthcare (ALHC)
$2.9B
Premier (PINC)
$2.2B
Ardent Health Partners (ARDT)
$2.1B
PACS (PACS)
$2.1B
GeneDx Holdings (WGS)
$2.1B
Progyny (PGNY)
$2B